Charlotte Rose Haigh

Ms. Charlotte Rose Haigh

Loughborough University, Loughborough, Leicestershire, UK

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 May 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
Jasmin HassanJasmin Hassan
Jasmin Hassan
Charlotte Rose HaighCharlotte Rose Haigh
Charlotte Rose Haigh
Tanvir AhmedTanvir Ahmed
Tanvir Ahmed
Md. Jasim UddinMd. Jasim Uddin
Md. Jasim Uddin
Diganta Bhusan DasDiganta Bhusan Das
Diganta Bhusan Das
To prevent the coronavirus disease 2019 (COVID-19) pandemic and aid restoration to prepandemic normality, global mass vaccination is urgently needed. Inducing herd immunity through mass vaccination has proven to be a highly effective strategy for preventing the spread of many infectious diseases, which protects the most vulnerable population groups that are unable to develop immunity, such as people with immunodeficiencies or weakened immune systems due to underlying medical or debilitating conditions. In achieving global outreach, the maintenance of the vaccine potency, transportation, and needle waste generation become major issues. Moreover, needle phobia and vaccine hesitancy act as hurdles to successful mass vaccination. The use of dissolvable microneedles for COVID-19 vaccination could act as a major paradigm shift in attaining the desired goal to vaccinate billions in the shortest time possible. In addressing these points, we discuss the potential of the use of dissolvable microneedles for COVID-19 vaccination based on the current literature.